# OnCo record eortc-22911 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eortc-22911/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eortc-22911", "NCT00002511" ;
  schema:name "EORTC 22911"@en ;
  schema:alternateName "EORTC 22911"@en ;
  schema:description "Radiotherapy given straight after prostate surgery kept the PSA down for longer, but over ten years that did not translate into fewer men whose disease actually progressed, and side effects were commoner."@en ;
  schema:url <https://onco.cc/trials/eortc-22911/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00002511>, <https://doi.org/10.1016/S0140-6736(12)61253-7> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:companies <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:terms <https://onco.cc/terms/prostatectomy/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/biochemical-recurrence/> ;
  onco:trials <https://onco.cc/trials/swog-8794/>, <https://onco.cc/trials/radicals-rt/>, <https://onco.cc/trials/artistic-meta-analysis/> .
